$TPHS
Trinity Place Holdings Inc. Stock $tphs

$tphs Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000155837022014237 Filed on September 07, 2022

Income Statement

Concept	2022 Q3	2022 Q2
Revenue	$19.01M	$6.359M
YoY Change	676.71%	663.39%
Cost Of Revenue	$1.706M	$1.182M
YoY Change	136.29%	-20.14%
Gross Profit	$17.30M	$5.177M
YoY Change	1008.26%	-747.93%
Gross Profit Margin	91.02%	81.41%
Selling, General & Admin	$1.431M	$1.503M
YoY Change	17.58%	21.7%
% of Gross Profit	8.27%	29.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$695.0K	$696.0K
YoY Change	71.18%	71.85%
% of Gross Profit	4.02%	13.44%
Operating Expenses	$21.02M	$8.649M
YoY Change	345.99%	112.87%
Operating Profit	-$2.009M	-$2.290M
YoY Change	-11.3%	-29.1%
Interest Expense	-$3.549M	-$3.295M
YoY Change	412.86%	273.16%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.271M	-$103.0K
YoY Change	348.25%	-97.91%
Income Tax	$82.00K	$120.0K
% Of Pretax Income
Net Earnings	-$6.353M	-$223.0K
YoY Change	369.9%	-95.57%
Net Earnings / Revenue	-33.43%	-3.51%
Basic Earnings Per Share	-$0.17	-$0.01
Diluted Earnings Per Share	-$0.17	-$0.01
COMMON SHARES
Basic Shares Outstanding	36.88M	36.85M
Diluted Shares Outstanding	37.26M	37.19M

Balance Sheet

Concept	2022 Q3	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.190M	$3.112M
YoY Change	138.82%	43.48%
Cash & Equivalents	$2.200M	$3.100M
Short-Term Investments
Other Short-Term Assets	$2.401M	$1.639M
YoY Change	175.03%	257.08%
Inventory
Prepaid Expenses
Receivables	$78.00K	$50.00K
Other Receivables	$123.0K	$121.0K
Total Short-Term Assets	$4.792M	$4.922M
YoY Change	142.14%	70.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.39M	$67.15M
YoY Change	-78.48%	-77.71%
Goodwill
YoY Change
Intangibles	$7.877M	$8.062M
YoY Change	-8.59%	-8.41%
Long-Term Investments	$4.500M	$4.600M
YoY Change	-11.76%	-9.8%
Other Assets	$210.7M	$228.0M
YoY Change	1696.13%	2890.27%
Total Long-Term Assets	$293.0M	$311.2M
YoY Change	-15.08%	-6.9%
TOTAL ASSETS
Total Short-Term Assets	$4.792M	$4.922M
Total Long-Term Assets	$293.0M	$311.2M
Total Assets	$297.8M	$316.1M
YoY Change	-14.18%	-6.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.66M	$22.82M
YoY Change	-9.74%	30.74%
Accrued Expenses	$1.141M	$1.245M
YoY Change	-24.74%	-18.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.80M	$24.07M
YoY Change	-10.88%	26.72%
LONG-TERM LIABILITIES
Long-Term Debt	$241.1M	$246.9M
YoY Change	-11.99%	-5.89%
Other Long-Term Liabilities	$151.0K	$215.0K
YoY Change	-89.3%	-93.13%
Total Long-Term Liabilities	$241.2M	$247.1M
YoY Change	-12.39%	-6.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.80M	$24.07M
Total Long-Term Liabilities	$241.2M	$247.1M
Total Liabilities	$259.0M	$271.2M
YoY Change	-12.29%	-4.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.90M	-$41.55M
YoY Change	81.86%	66.27%
Common Stock	$145.2M	$145.0M
YoY Change	5.91%	6.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$57.46M	$57.46M
YoY Change	0.52%	0.52%
Treasury Stock Shares	$6.541M	$6.541M
Shareholders Equity	$38.81M	$44.90M
YoY Change
Total Liabilities & Shareholders Equity	$297.8M	$316.1M
YoY Change	-14.18%	-6.24%

Cashflow Statement

Concept	2022 Q3	2022 Q2
OPERATING ACTIVITIES
Net Income	-$6.353M	-$223.0K
YoY Change	369.9%	-95.57%
Depreciation, Depletion And Amortization	$695.0K	$696.0K
YoY Change	71.18%	71.85%
Cash From Operating Activities	$6.458M	$989.0K
YoY Change	4648.53%	136.6%
INVESTING ACTIVITIES
Capital Expenditures	-$25.00K	$4.636M
YoY Change	-99.73%	-150.2%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$11.78M
YoY Change	-100.0%
Cash From Investing Activities	-$25.00K	$16.42M
YoY Change	-99.69%	-277.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.15M	-16.63M
YoY Change	-203.38%	-341.59%
NET CHANGE
Cash From Operating Activities	6.458M	989.0K
Cash From Investing Activities	-25.00K	16.42M
Cash From Financing Activities	-11.15M	-16.63M
Net Change In Cash	-4.719M	778.0K
YoY Change	-265.35%	-140.25%
FREE CASH FLOW
Cash From Operating Activities	$6.458M	$989.0K
Capital Expenditures	-$25.00K	$4.636M
Free Cash Flow	$6.483M	-$3.647M
YoY Change	-31.99%	-137.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2021Q3	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q3	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q3	tphs	Special Stock Value SpecialStockValue
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	dei	Entity Central Index Key EntityCentralIndexKey	0000724742
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2022Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2022Q1	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2022Q1	tphs	Special Stock Value SpecialStockValue
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	dei	Document Type DocumentType	10-Q
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-08546
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2465228
	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2022Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	215000
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1146000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2007000
CY2022Q2	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000000
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32591000
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37186000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32694000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37145000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32643000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32694000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32643000
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32756000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32681000
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33322000
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37104000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37104000
CY2022Q2	tphs	Special Stock Value SpecialStockValue
CY2021Q4	tphs	Special Stock Value SpecialStockValue
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
	tphs	Gain On Sale Of Joint Venture Real Estate GainOnSaleOfJointVentureRealEstate
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit
CY2020Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2020Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2020Q4	tphs	Special Stock Value SpecialStockValue
CY2021Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q1	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q1	tphs	Special Stock Value SpecialStockValue
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q2	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q2	tphs	Special Stock Value SpecialStockValue
	dei	Entity Registrant Name EntityRegistrantName	TRINITY PLACE HOLDINGS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36877140
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	8649000
	dei	Entity Address Address Line1 EntityAddressAddressLine1	340 Madison Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10173
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	235-2190
	dei	Security12b Title Security12bTitle	Common Stock $0.01 Par Value Per Share
	dei	Trading Symbol TradingSymbol	TPHS
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	66016000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	67334000
CY2022Q2	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	214759000
CY2021Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	216983000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3112000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	13279000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4915000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4126000
CY2022Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4643000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	50000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	84000
CY2022Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	121000
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	114000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1132000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1314000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8062000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8432000
CY2022Q2	us-gaap	Assets Assets	316089000
CY2021Q4	us-gaap	Assets Assets	341170000
CY2022Q2	us-gaap	Loans Payable LoansPayable	198458000
CY2021Q4	us-gaap	Loans Payable LoansPayable	219249000
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	33337000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	32844000
CY2022Q2	us-gaap	Secured Debt SecuredDebt	9250000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	12750000
CY2022Q2	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22824000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17864000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1245000
CY2022Q2	us-gaap	Liabilities Liabilities	271192000
CY2021Q4	us-gaap	Liabilities Liabilities	291163000
CY2022Q2	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1106000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1343000
	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	315000
	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	325000
CY2022Q2	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	4803000
	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	10524000
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1004000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43390895
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36850373
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	434000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	430000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144580000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144282000
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	6540522
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	57461000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41550000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36196000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	44897000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	316089000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341170000
CY2022Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1231000
CY2021Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	577000
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	2491000
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1024000
CY2022Q2	us-gaap	Other Income OtherIncome	10000
CY2021Q2	us-gaap	Other Income OtherIncome	256000
	us-gaap	Other Income OtherIncome	26000
	us-gaap	Other Income OtherIncome	302000
CY2022Q2	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	5118000
	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	11187000
CY2022Q2	us-gaap	Revenues Revenues	6359000
CY2021Q2	us-gaap	Revenues Revenues	833000
	us-gaap	Revenues Revenues	13704000
	us-gaap	Revenues Revenues	1326000
CY2022Q2	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	766000
CY2021Q2	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1888000
	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1570000
	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	3795000
CY2022Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	416000
CY2021Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	806000
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	158000
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1503000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1387000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3005000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2630000
CY2022Q2	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	157000
CY2021Q2	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	162000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	4516000
	us-gaap	Operating Expenses OperatingExpenses	18227000
	us-gaap	Operating Expenses OperatingExpenses	8908000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2290000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3683000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4523000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7582000
CY2022Q2	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	70000
CY2021Q2	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	-264000
	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	816000
	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	-636000
CY2022Q2	tphs	Income Loss From Equity Method Investments Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsGainOnSaleOfProperty	4490000
	tphs	Income Loss From Equity Method Investments Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsGainOnSaleOfProperty	4490000
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1300000
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-931000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1910000
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3295000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1772000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6064000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2647000
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	378000
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	683000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	814000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	944000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-103000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6335000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5164000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13719000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	120000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	190000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-223000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6434000
	us-gaap	Net Income Loss NetIncomeLoss	-5354000
	us-gaap	Net Income Loss NetIncomeLoss	-13853000
CY2022Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	118000
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	118000
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	237000
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	237000
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-105000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6316000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5117000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13616000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37186000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32694000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37145000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32643000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	44873000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-223000
CY2022Q2	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-118000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	129000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	44897000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
	us-gaap	Net Income Loss NetIncomeLoss	-5354000
	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-291000
	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-237000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	298000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	44897000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	54523000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6434000
CY2021Q2	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	1000
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-118000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	48386000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
	us-gaap	Net Income Loss NetIncomeLoss	-13853000
	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-369000
	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-237000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	351000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	48386000
	us-gaap	Profit Loss ProfitLoss	-5354000
	us-gaap	Profit Loss ProfitLoss	-13853000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2821000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2944000
	us-gaap	Share Based Compensation ShareBasedCompensation	271000
	us-gaap	Share Based Compensation ShareBasedCompensation	265000
	tphs	Gain On Sale Of Joint Venture Real Estate GainOnSaleOfJointVentureRealEstate	4490000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16000
	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-237000
	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-238000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-931000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1910000
	tphs	Income Loss From Equity Method Investments Cash Flow IncomeLossFromEquityMethodInvestmentsCashFlow	816000
	tphs	Income Loss From Equity Method Investments Cash Flow IncomeLossFromEquityMethodInvestmentsCashFlow	-636000
	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	1183000
	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	425000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243000
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-5676000
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	19479000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-34000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-820000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1041000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	97000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2787000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3559000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	370000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22891000
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	68000
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	56000
	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	17418000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17350000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56000
	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	4666000
	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	74486000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1200000
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2231000
	tphs	Repayments Of Loans RepaymentsOfLoans	27049000
	tphs	Repayments Of Loans RepaymentsOfLoans	56413000
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3500000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	291000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	369000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26174000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16673000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8454000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6274000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16391000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9795000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3112000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2169000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	13279000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7626000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16391000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9795000
	us-gaap	Interest Paid Net InterestPaidNet	4970000
	us-gaap	Interest Paid Net InterestPaidNet	8564000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	251000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	49000
	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	1272000
	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	1501000
	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	27000
	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	70000
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 – Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Trinity Place Holdings Inc., which we refer to in these financial statements as “Trinity,” “we,” “our,” or “us,” is a real estate holding, investment, development and asset management company. Our largest asset is currently a property located at 77 Greenwich Street in Lower Manhattan (“77 Greenwich”), which is nearing completion of development as a mixed-use project consisting of a 90-unit residential condominium tower, retail space and a New York City elementary school. We also own a recently built 105-unit, 12-story multi-family property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street in Brooklyn, New York (“237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), and, through a joint venture, a 10% interest in a recently built 234-unit multi-family property at 250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> street in Brooklyn, New York (“250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), as well as a property occupied by retail tenants in Paramus, New Jersey. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We also control a variety of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (“Syms”), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and An Educated Consumer is Our Best Customer® slogan. In addition, we had approximately $261.8 million of federal net operating loss carryforwards (“NOLs”) at June 30, 2022, which can be used to reduce our future taxable income and capital gains.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 Pandemic, Management’s Plans and Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As a result of the COVID-19 pandemic, numerous federal, state, local and foreign governmental authorities issued a range of “stay-at-home orders”, proclamations and directives aimed at minimizing the spread of COVID-19, among other restrictions on businesses and individuals. Additional proclamations and directives have been issued in response to further outbreaks, and may be issued in the future. The outbreak and restrictions have adversely affected our business operations including, among other things, a temporary suspension of construction work at our most significant asset, 77 Greenwich, which resumed in mid-April 2020, initially on a modified basis, as certain work was deemed “essential” construction, and the temporary closing of the sales center for the 77 Greenwich residential condominium units as well as the temporary suspension of the remediation work being performed on 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>, which resumed in early June 2020 and was completed in the fourth quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The economic downturn and volatility in financial markets appear to have been primarily driven by uncertainties associated with the pandemic. As it relates to our business, these uncertainties include, but are not limited to, the adverse effect of the pandemic on the New York City and broader economy, residential and potential residential sentiment in New York City, particularly Manhattan, lending institutions, construction and material supply partners, travel and transportation services, our employees, residents and tenants, and traffic to and within geographic areas containing our real estate assets. The pandemic has adversely affected our short-term, and may adversely affect our long-term, liquidity, cash flows and revenues and has required and may continue to require significant actions in response, including, but not limited to, reducing or discounting prices for our residential condominium units more than originally budgeted, seeking loan extensions and covenant modifications, modifying, eliminating or deferring rent payments in the short term for tenants in an effort to mitigate financial hardships. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The ultimate impact of the COVID-19 pandemic on our operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, new and recurring outbreaks, new information which may emerge concerning the pandemic and any additional preventative and protective actions that governments, lending institutions and other businesses, including us, may direct or institute. These and other developments have resulted in and may continue to result in an extended period of continued business disruption and reduced operations for us as well as for lending and other businesses and governmental entities with which we do business. The ultimate financial impacts cannot be reasonably estimated at this time but the outbreak, restrictions and future developments are anticipated to continue to have an adverse impact on our business, financial condition and results of operations, which has been and may continue to be material, although in recent months we have seen indications of a recovery in the New York City real estate market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The measures taken to date, together with any additional measures and developments including those noted above, impacted and will continue to impact the Company’s business in 2022 and beyond, although the extent of the significance of the impact of the COVID-19 outbreak on our business and the duration for which it may have an impact cannot be determined at this time. Although the impact of the pandemic, as well as, more recently, the war in Ukraine and rising interest rates, has impeded the sale of residential condominium units at 77 Greenwich, we have closed on 19 residential condominium units as of June 30, 2022 and an additional two units in July 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. Given the impacts of COVID-19 and supply-chain issues, while construction at 77 Greenwich is in the final stage of completion, it has taken longer than projected. As a result, we expect certain items, including punch-list items, the outside dog run and general contractor settlements, to not be completed by the Final Completion milestone of September 28, 2022 as contemplated under our 77 Mortgage Loan and mezzanine loan. Missing this deadline will trigger certain events of default under the 77 Mortgage Loan and mezzanine loan facility, creating substantial doubt about our ability to continue as a going concern. Although the impact of the pandemic has impeded the sale of residential condominium units at 77 Greenwich, we continue to sign and close contracts for our residential condominium units. Many residents have moved into the building. The majority of the construction is expected to be completed by the end of September, including the remaining residential units and amenity spaces, with punch-list and general contractor settlements to follow. Management has already held productive discussions with our 77 Mortgage Lender and currently expects to enter into an amendment to the 77 Mortgage Loan agreement and the mezzanine loan to extend the Final Completion milestone within the next several weeks. If we are not successful in completing the amendment as contemplated above, and the 77 Mortgage Lender or the lender under our mezzanine loan facility accelerated their respective loan, cross-defaults would also exist and we would have insufficient cash and liquidity to service our debt and pay operating expenses and other obligations. The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to our ability to continue as a going concern. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As of June 30, 2022, we had total cash and restricted cash of $16.4 million, of which approximately $3.1 million was cash and cash equivalents and approximately $13.3 million was restricted cash as well as $3.5 million available under our secured line of credit. At this time, we believe our existing balances of cash and cash equivalents, secured line of credit availability, planned refinancing of the Paramus line of credit or sale of the Paramus property and sales of the larger, higher floor condominium units at 77 Greenwich will be sufficient to satisfy our working capital needs and projected capital and other expenditures associated with our operations over the next 12 months, unless we are unable to reach agreement with our lenders as described above. Additionally, management continues to evaluate opportunities to raise capital through sales of equity, including under our ATM program, debt issuances or refinancings, including refinancing the property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, and continues to evaluate dispositions of other properties or other assets and/or sales of partial interests in properties. In addition, management is actively engaging with parties who have expressed interest in the Company’s assets and attributes, and may consider from time to time potential strategic transactions, including acquisition, disposition, and financing and refinancings. Facts and circumstances that are outside of management’s control could change in the future, such as additional government mandates, health official orders, travel restrictions and extended business shutdowns due to COVID-19, and the impact of such matters on residential sentiment in New York City in particular. </p>
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16400000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3100000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	13300000
CY2022Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	3500000
CY2021Q4	us-gaap	Tenant Improvements TenantImprovements	200000
CY2022Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	822000
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	775000
CY2022Q2	us-gaap	Land And Land Improvements LandAndLandImprovements	28847000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">c. <i style="font-style:italic;">Use of Estimates</i> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates.</p>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">e. <i style="font-style:italic;">Concentrations of Credit Risk</i> - Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. We hold substantially all of our cash and cash equivalents in banks. Such cash balances at times exceed federally insured limits.</p>
CY2022Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	4541000
CY2021Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	5284000
CY2021Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	28847000
CY2022Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	81031000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	80963000
	us-gaap	Interest Costs Incurred InterestCostsIncurred	8828000
	us-gaap	Interest Costs Incurred InterestCostsIncurred	10272000
CY2022Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	51141000
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	51141000
CY2022Q2	us-gaap	Tenant Improvements TenantImprovements	221000
CY2022Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	15015000
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	13629000
CY2022Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	66016000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	67334000
CY2022Q2	us-gaap	Depreciation Depreciation	696000
CY2021Q2	us-gaap	Depreciation Depreciation	693000
	us-gaap	Depreciation Depreciation	1400000
	us-gaap	Depreciation Depreciation	1400000
	tphs	Percentage Of Property Leased PercentageOfPropertyLeased	0.991
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11100000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11100000
	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	3000000.0
CY2021	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2700000
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	185000
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	185000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	370000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	370000
CY2022Q2	tphs	Aggregate Fees Paid By Sca To Company AggregateFeesPaidByScaToCompany	46100000
CY2022Q2	tphs	Remaining Fees To Be Paid By Sca To Company RemainingFeesToBePaidByScaToCompany	420000
CY2022Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1246000
CY2021Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	3511000
CY2022Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1639000
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	673000
CY2022Q2	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2021Q4	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2022Q2	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2811000
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2736000
CY2022Q2	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	6634000
CY2021Q4	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	5593000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1719000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1467000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4915000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4126000
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4400000
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3800000
CY2022Q2	tphs	Maximum Number Of Board Committees In Which Designee Can Sit MaximumNumberOfBoardCommitteesInWhichDesigneeCanSit	3
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	217098000
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	35750000
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	252848000
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5940000
CY2022Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	246908000
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	2764000
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	7624000
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther	1000
	us-gaap	Interest Income Other InterestIncomeOther	1000
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3295000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1772000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6064000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2647000
CY2022Q2	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43390895
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36850373
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2019Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7179000
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.50
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	0
	tphs	Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1500000
CY2021	tphs	Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized	0
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	50947
	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.87
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	107754
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.77
	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployee	60500
CY2022Q2	tphs	Federal Net Operating Loss Carryforwards Utilized To Date FederalNetOperatingLossCarryforwardsUtilizedToDate	22500000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	72600000
CY2022Q2	tphs	Capital Stock Shares Authorized CapitalStockSharesAuthorized	120000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2019Q4	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2019Q4	tphs	Warrant Agreement Threshold Maximum Percentage Of Issued And Outstanding Common Stock After Exercise Of Warrants WarrantAgreementThresholdMaximumPercentageOfIssuedAndOutstandingCommonStockAfterExerciseOfWarrants	0.199
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	215000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1100000
	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	931000
	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	-1900000
CY2022Q2	tphs	Warrant Holder S Right Number Of Board Members To Appoint WarrantHolderSRightNumberOfBoardMembersToAppoint	1
	tphs	Warrant Agreement Preemptive Rights Period WarrantAgreementPreemptiveRightsPeriod	P5Y
CY2022Q2	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2019Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000.0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	250197
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	483361
	tphs	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	1.93
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4500000
CY2022Q2	tphs	Special Stock Shares Authorized SpecialStockSharesAuthorized	1
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	548370
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployeeWeightedAverageGrantDateFairValue	1.68
CY2021	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployee	0
CY2021	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployeeWeightedAverageGrantDateFairValue	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1216583
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022Q2	tphs	Deferred Compensation Arrangement With Individual Shares Outstanding DeferredCompensationArrangementWithIndividualSharesOutstanding	335860
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	4600000
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	77000
CY2021Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	369000
CY2022Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4643000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4560000
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-264000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5306000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	70040000
CY2020Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	203276000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2703000
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	19379000
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	966000
CY2020Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	90000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1565000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9172000
CY2020Q4	us-gaap	Assets Assets	323260000
CY2020Q4	us-gaap	Loans Payable LoansPayable	197330000
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	31858000
CY2020Q4	us-gaap	Secured Debt SecuredDebt	7747000
CY2020Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	15896000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1716000
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	830000
CY2020Q4	us-gaap	Liabilities Liabilities	261240000
CY2020Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38345540
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32172107
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	383000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	135978000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6173433
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	56791000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2159000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15391000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	323260000
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1563000
CY2020	us-gaap	Other Income OtherIncome	263000
CY2020	us-gaap	Revenues Revenues	1826000
CY2020	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	9120000
CY2020	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	254000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5217000
CY2020	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	345000
CY2020	us-gaap	Recapitalization Costs RecapitalizationCosts	133000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3907000
CY2020	us-gaap	Operating Expenses OperatingExpenses	18976000
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	7046000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1571000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1540000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	261000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4639000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4333000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1015000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5348000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32305000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32860000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55964000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4333000
CY2020	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-696000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-1015000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1163000
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	600000
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	359000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
CY2020	us-gaap	Profit Loss ProfitLoss	4333000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4168000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	806000
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	84000
CY2020	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-1015000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1571000
CY2020	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	1110000
CY2020	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	46473000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2392000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-190000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1285000
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1033000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55881000
CY2020	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	4279000
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	5383000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9662000
CY2020	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	86361000
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	5000000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1497000
CY2020	tphs	Repayments Of Loans RepaymentsOfLoans	23368000
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2500000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	695000
CY2020	tphs	Proceeds From Stock Buy Back ProceedsFromStockBuyBack	359000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62942000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2601000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9196000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9474000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	15495000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	251000
CY2020	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2668000
CY2020	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	299000
CY2020	tphs	Noncash Investment In Unconsolidated Joint Venture NoncashInvestmentInUnconsolidatedJointVenture	5193000
CY2021Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	69353000
CY2021Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	213223000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5034000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6694000
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3343000
CY2021Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18814000
CY2021Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	919000
CY2021Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	102000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1478000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8987000
CY2021Q1	us-gaap	Assets Assets	327947000
CY2021Q1	us-gaap	Loans Payable LoansPayable	207317000
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	32104000
CY2021Q1	us-gaap	Secured Debt SecuredDebt	8950000
CY2021Q1	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14368000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1626000
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3196000
CY2021Q1	us-gaap	Liabilities Liabilities	273424000
CY2021Q1	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38840508
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32442633
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	388000
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136151000
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2040000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22810000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	54523000
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	327947000
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	447000
CY2021Q1	us-gaap	Other Income OtherIncome	46000
CY2021Q1	us-gaap	Revenues Revenues	493000
CY2021Q1	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1907000
CY2021Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1243000
CY2021Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	163000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	4392000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3899000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1977000
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-875000
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	261000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7384000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7419000
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7300000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32591000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7419000
CY2021Q1	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	54523000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-7419000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1261000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	133000
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	12000
CY2021Q1	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-119000
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1977000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-372000
CY2021Q1	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	194000
CY2021Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	11672000
CY2021Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-47000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	371000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1294000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14077000
CY2021Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	53000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53000
CY2021Q1	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	8980000
CY2021Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1200000
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	21000
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9789000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4341000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5034000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6694000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	4130000
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	46000
CY2021Q1	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	692000
CY2021Q1	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	37000
CY2021Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	68663000
CY2021Q2	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	222713000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2169000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7626000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2934000
CY2021Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18318000
CY2021Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	146000
CY2021Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	106000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1389000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8802000
CY2021Q2	us-gaap	Assets Assets	332866000
CY2021Q2	us-gaap	Loans Payable LoansPayable	215193000
CY2021Q2	us-gaap	Line Of Credit LineOfCredit	32351000
CY2021Q2	us-gaap	Secured Debt SecuredDebt	8950000
CY2021Q2	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17458000
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1536000
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3129000
CY2021Q2	us-gaap	Liabilities Liabilities	284480000
CY2021Q2	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38853433
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32455568
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	389000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136329000
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1922000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29244000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	48386000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	332866000
CY2021Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	577000
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1024000
CY2021Q2	us-gaap	Other Income OtherIncome	256000
	us-gaap	Other Income OtherIncome	302000
CY2021Q2	us-gaap	Revenues Revenues	833000
	us-gaap	Revenues Revenues	1326000
CY2021Q2	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	1888000
	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	3795000
CY2021Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	158000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1387000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2630000
CY2021Q2	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	162000
	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	325000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	4516000
	us-gaap	Operating Expenses OperatingExpenses	8908000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3683000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7582000
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-264000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1910000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1772000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2647000
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	683000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	944000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6335000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13719000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6434000
	us-gaap	Net Income Loss NetIncomeLoss	-13853000
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	118000
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	237000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6316000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13616000
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32694000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32643000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	54523000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6434000
CY2021Q2	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	1000
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-118000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	48386000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
	us-gaap	Net Income Loss NetIncomeLoss	-13853000
	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-369000
	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-237000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	351000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	48386000
	us-gaap	Profit Loss ProfitLoss	-13853000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2944000
	us-gaap	Share Based Compensation ShareBasedCompensation	265000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16000
	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-238000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1910000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	425000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243000
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	19479000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-820000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	97000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3559000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22891000
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	56000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56000
	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	74486000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1200000
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2231000
	tphs	Repayments Of Loans RepaymentsOfLoans	56413000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	369000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16673000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6274000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9795000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2169000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7626000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9795000
	us-gaap	Interest Paid Net InterestPaidNet	8564000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	49000
	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	1501000
	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	70000
CY2021Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	67996000
CY2021Q3	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	228102000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	917000
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11732000
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3555000
CY2021Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18056000
CY2021Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	79000
CY2021Q3	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	110000
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1374000
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8617000
CY2021Q3	us-gaap	Assets Assets	340538000
CY2021Q3	us-gaap	Loans Payable LoansPayable	223503000
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	32597000
CY2021Q3	us-gaap	Secured Debt SecuredDebt	11950000
CY2021Q3	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	18457000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1516000
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1411000
CY2021Q3	us-gaap	Liabilities Liabilities	295297000
CY2021Q3	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39016012
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32618137
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	390000
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136672000
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1803000
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32852000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	45241000
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	340538000
CY2021Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	967000
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1991000
CY2021Q3	us-gaap	Other Income OtherIncome	30000
	us-gaap	Other Income OtherIncome	332000
CY2021Q3	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	1428000
	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	1428000
CY2021Q3	us-gaap	Revenues Revenues	2425000
	us-gaap	Revenues Revenues	3751000
CY2021Q3	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	897000
	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	4692000
CY2021Q3	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	271000
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	429000
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1440000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4070000
CY2021Q3	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	158000
	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	483000
CY2021Q3	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	1395000
	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	1395000
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1001000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3001000
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	5162000
	us-gaap	Operating Expenses OperatingExpenses	14070000
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2737000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10319000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1718000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	192000
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2367000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-5014000
CY2021Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	269000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1213000
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3655000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17374000
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-47000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	87000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3608000
	us-gaap	Net Income Loss NetIncomeLoss	-17461000
CY2021Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	356000
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3489000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17105000
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32756000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32681000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	48386000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3608000
CY2021Q3	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	166000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	45241000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
	us-gaap	Net Income Loss NetIncomeLoss	-17461000
	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-356000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	167000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	529000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	45241000
	us-gaap	Profit Loss ProfitLoss	-17461000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4214000
	us-gaap	Share Based Compensation ShareBasedCompensation	399000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20000
	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-356000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	192000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-636000
	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	686000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243000
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	25371000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-887000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	846000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5775000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30796000
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	84000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84000
	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	82318000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	4200000
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2442000
	tphs	Repayments Of Loans RepaymentsOfLoans	56413000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	167000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27460000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3420000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12649000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	917000
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11732000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12649000
	us-gaap	Interest Paid Net InterestPaidNet	13329000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	189000
	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2169000
	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	97000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	67334000
CY2021Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	216983000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4126000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	84000
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	114000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1314000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8432000
CY2021Q4	us-gaap	Assets Assets	341170000
CY2021Q4	us-gaap	Loans Payable LoansPayable	219249000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	32844000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	12750000
CY2021Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17864000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1146000
CY2021Q4	us-gaap	Liabilities Liabilities	291163000
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	430000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144282000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1343000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36196000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341170000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	3225000
CY2021	us-gaap	Other Income OtherIncome	355000
CY2021	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	23685000
CY2021	us-gaap	Revenues Revenues	27265000
CY2021	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	5583000
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	724000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5133000
CY2021	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	67000
CY2021	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	22370000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4003000
CY2021	us-gaap	Operating Expenses OperatingExpenses	37880000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10615000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-7922000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1521000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20540000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20805000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	816000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19989000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33322000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20805000
CY2021	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-816000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7639000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	707000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
CY2021	us-gaap	Profit Loss ProfitLoss	-20805000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5524000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	530000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24000
CY2021	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-816000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000
CY2021	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	885000
CY2021	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	11450000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-882000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	257000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3467000
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1288000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21238000
CY2021	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	140000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-140000
CY2021	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	249984000
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	8200000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6552000
CY2021	tphs	Repayments Of Loans RepaymentsOfLoans	225547000
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3200000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7639000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30154000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8776000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	16042000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	395000
CY2021	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	3193000
CY2021	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	122000
CY2021	tphs	Loan Forgiveness Non Cash LoanForgivenessNonCash	243000
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	66705000
CY2022Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	214591000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1381000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14232000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5007000
CY2022Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	18517000
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	60000
CY2022Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	118000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1224000
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8247000
CY2022Q1	us-gaap	Assets Assets	330082000
CY2022Q1	us-gaap	Loans Payable LoansPayable	210768000
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	33090000
CY2022Q1	us-gaap	Secured Debt SecuredDebt	12750000
CY2022Q1	us-gaap	Notes Payable NotesPayable	5863000
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19876000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1347000
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1515000
CY2022Q1	us-gaap	Liabilities Liabilities	285209000
CY2022Q1	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43387563
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36836146
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	434000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144451000
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	6551447
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	57461000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1224000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41327000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	44873000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	330082000
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1260000
CY2022Q1	us-gaap	Other Income OtherIncome	16000
CY2022Q1	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	6069000
CY2022Q1	us-gaap	Revenues Revenues	7345000
CY2022Q1	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	804000
CY2022Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	390000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1502000
CY2022Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	158000
CY2022Q1	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	5721000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1003000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	9578000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2233000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	746000
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	369000
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2769000
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	436000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5061000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5131000
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	119000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5012000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37104000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5131000
CY2022Q1	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-291000
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-119000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	169000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	44873000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-5131000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1439000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	123000
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4000
CY2022Q1	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-119000
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	369000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	746000
CY2022Q1	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	168000
CY2022Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-3548000
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-24000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1008000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1474000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	375000
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	64000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64000
CY2022Q1	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	2390000
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	11642000
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	291000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9543000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9232000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15613000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1381000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14232000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15613000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	3050000
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	66000
CY2022Q1	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	583000
CY2022Q1	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	18000

Files In Submission

Name	View Source	Status
0001558370-22-014237-index-headers.html	Edgar Link	pending
0001558370-22-014237-index.html	Edgar Link	pending
0001558370-22-014237.txt	Edgar Link	pending
0001558370-22-014237-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tphs-20220630.xsd	Edgar Link	pending
tphs-20220630x10q.htm	Edgar Link	pending
tphs-20220630xex31d1.htm	Edgar Link	pending
tphs-20220630xex31d2.htm	Edgar Link	pending
tphs-20220630xex32d1.htm	Edgar Link	pending
tphs-20220630xex32d2.htm	Edgar Link	pending
tphs-20220630_cal.xml	Edgar Link	unprocessable
tphs-20220630_def.xml	Edgar Link	unprocessable
tphs-20220630_lab.xml	Edgar Link	unprocessable
tphs-20220630_pre.xml	Edgar Link	unprocessable
tphs-20220630x10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TPHS
Trinity Place Holdings Inc. Stock $tphs

2022 Q3 Form 10-Q Financial Statement

#000155837022014237 Filed on September 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS Trinity Place Holdings Inc. Stock $tphs

2022 Q3 Form 10-Q Financial Statement

#000155837022014237 Filed on September 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS
Trinity Place Holdings Inc. Stock $tphs